Joshua Daniel
Upstream Process Development Research Associate at TCR2 Therapeutics - Cambridge, MA, US
Joshua Daniel's Colleagues at TCR2 Therapeutics
Joshua Daniel's Contact Details
617-949-5200
Cambridge, Massachusetts
TCR2 Therapeutics
Joshua Daniel's Company Details
TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.